🔗 Permalink

Inventor profile of:

Michael J. Ackerman

City:

Rochester, Minnesota

Country:

United States

Published Applications:

Last publication date:

2025-09-11

Top Assignees for applications by Michael J. Ackerman

The entities that hold a legal rights for patent applications filed by inventor Ackerman Michael J.:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 6 Rochester, MN United States
Mayo Clinic Health Solutions 1 Rochester, MN United States
WISCONSIN ALUMNI RESEARCH FOUNDATION 1 Madison, WI United States

Recent patent applications by Ackerman Michael J.

Michael J. Ackerman from Rochester, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11

US20250284950A1

Physics

SYSTEM, METHOD, AND APPARATUS FOR IDENTIFYING CONGENITAL LONG QT SYNDROME IN A SUBJECT

#2 | 2024-03-21

US20240093202A1

Chemistry; metallurgy

Suppression-Replacement Gene Therapy

#3 | 2021-09-09

US20210275080A1

Human necessities

Electrocardiogram analytical tool

#4 | 2019-08-15

US20190246966A1

Human necessities

ECG-based analyte assessments with adjustments for variances in patient posture

#5 | 2018-12-06

US20180350468A1

Physics

PROCESSING PHYSIOLOGICAL ELECTRICAL DATA FOR ANALYTE ASSESSMENTS

#6 | 2016-09-08

US20160256063A1

Human necessities

ANALYTE ASSESSMENT AND ARRHYTHMIA RISK PREDICTION USING PHYSIOLOGICAL ELECTRICAL DATA

#7 | 2010-01-07

US20100003690A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR DISCOVERING AGENTS FOR PHARMACOLOGICAL RESCUE OF HERG 1B SUBUNITS FOR THE TREATMENT OF LONG QT SYNDROME

#8 | 2009-02-03

US10632342

Nucleic acid encoding sodium channel subunit

#9 | 2008-11-20

US20080286875A1

Physics

RYR2 MUTATIONS

#10 | 2007-09-06

US20070207473A1

Chemistry; metallurgy

Identifying susceptibility to cardiac hypertrophy

#11 | 2005-06-30

US20050142591A1

Chemistry; metallurgy

Method of genetic testing in heritable arrhythmia syndrome patients

InventorID:

1640697 ⎘